SAB05

About Santa Ana Bio

Santa Ana Bio is a San Diego-based biotech focused on precision therapeutics for autoimmune and inflammatory disorders. The company's core strategy is built on a proprietary multi-omics platform that integrates genomic, transcriptomic, and proteomic data to identify specific molecular drivers of disease, enabling the design of highly targeted biologics. Its pipeline features three core programs: a bispecific for mast cell depletion (SAB01), a CD40-targeted glucocorticoid ADC (SAB05), and a portfolio of multi-specifics for GI diseases (SAB06), all in preclinical development. Santa Ana Bio aims to move beyond broad-spectrum immunosuppression by creating therapies with meticulous accuracy and improved safety profiles.

Therapeutic Areas